Updated Survival Results of BBCAPX-II: Sintilimab Combined with Bevacizumab and CapeOx As First-Line Treatment in Patients with RAS-mutant, Microsatellite Stable, Unresectable Metastatic Colorectal Cancer.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined